Table 2.
Comparison of Individuals With Sarcopenia With Those Without Sarcopenia
| Sarcopenia (n = 41) | No Sarcopenia (n = 50) | P | |
|---|---|---|---|
| Age, years, mean (95% CI) | 41 (35.9–46.1) | 40 (35.7–44.3) | 0.917 |
| Male sex, n (%) | 10 (24.4) | 35 (70) | <0.001 |
| Disease duration, years, mean (95% CI) | 11.6 (7.5–15.8) | 9.4 (6.8–13.1) | 0.915 |
| CD, n (%) | 22 (53.7) | 37 (74) | 0.05 |
| UC, n (%) | 19 (46.3) | 13 (26) | 0.05 |
| BMI, mean (95% CI) | 24.2 (22.5–26) | 26.2 (24.3–28.1) | 0.186 |
| Past smoking, n (%) | 25 (65.8) | 21 (53.9) | 0.354 |
| Major surgery, n (%) | 29 (70.7) | 38 (76) | 0.636 |
| WBC, 109/L, mean (95% CI) | 11.8 (10.1–13.5) | 11 (10.1–12) | 0.801 |
| Hemoglobin, g/dL, mean (95% CI) | 10.7 (10.2–11.3) | 11.1 (10.6–11.6) | 0.458 |
| Platelet count, 109/L, mean (95% CI) | 267.8 (240.9–294.8) | 249.3 (223.5–275.1) | 0.206 |
| Albumin, g/dL, mean (95% CI) | 3.1 (2.8–3.4) | 3.5 (3.3–3.8) | 0.028 |
| CRP, mg/L, mean (95% CI) | 42.2 (25.9–58.5) | 43.7 (2.6–66.7) | 0.554 |
| Protein, g/dL, mean (95% CI) | 6.2 (5.8–6.6) | 6.7 (6.4–7.1) | 0.093 |
| BUN, mg/dL, mean (95% CI) | 9 (7.9–10.2) | 11.1 (8.4–13.9) | 0.797 |
| Creatinine, mg/dL, mean (95% CI) | 1 (0.7–1.2) | 1.1 (0.8–1.3) | 0.047 |
| PNI, mean (95% CI) | 34.2 (29.4–39.1) | 36.5 (32.1–41) | 0.284 |
| NRI, mean (95% CI) | 91.4 (84.3–98.5) | 102.9 (96.7–109.2) | 0.0211 |
| Steroid use, n (%) | 14 (34.2) | 16 (32) | 1 |
| Immunomodulator, n (%) | 4 (9.8) | 8 (16) | 0.536 |
| Anti-TNF, n (%) | 3 (7.3) | 7 (14) | 0.503 |
| Anti-integrin, n (%) | 9 (22) | 12 (24) | 1 |
Bold: P-value < 0.05.
BUN, blood urea nitrogen; CRP, C-reactive protein; TNF, tumor necrosis factor; WBC, white blood cell.